Skip to main content
Molecular Therapy logoLink to Molecular Therapy
. 2023 Dec 19;32(2):559–561. doi: 10.1016/j.ymthe.2023.12.013

Neuropeptide Y attenuates cardiac remodeling and deterioration of function following myocardial infarction

Yu-Yan Qin, Xiao-Ru Huang, Jian Zhang, Wenjing Wu, Junzhe Chen, Song Wan, Xi-Yong Yu ∗∗, Hui-Yao Lan ∗
PMCID: PMC10861985  PMID: 38118444

Main text

(Molecular Therapy 30, 881–897; February 2022)

In the originally published version of this article, a micrograph has been duplicated between Figures 6E and 7B. We found that Figure 7B was an error and was corrected and enclosed here. The authors apologize for any inconvenience.

graphic file with name gr7c.jpg

Figure 7. NPY switches M1 macrophages to M2 phenotype, which is abrogated by NPY Y1Ra BIBP in a mouse model of AMI and BMDMs (corrected)

graphic file with name gr7o.jpg

Figure 7. NPY switches M1 macrophages to M2 phenotype, which is abrogated by NPY Y1Ra BIBP in a mouse model of AMI and BMDMs (original)

Contributor Information

Xi-Yong Yu, Email: yuxycn@aliyun.com.

Hui-Yao Lan, Email: hylan@cuhk.edu.hk.


Articles from Molecular Therapy are provided here courtesy of The American Society of Gene & Cell Therapy

RESOURCES